Shilpa Medicare arm, PPI to form new JV company in Saudi Arabia

Written by Ruchika Sharma Published On 2025-08-28T12:21:54+05:30 | Updated On 28 Aug 2025 12:21 PM IST

Shilpa Medicare arm, PPI to form new JV company in Saudi Arabia

Raichur: Koanna International FZ LLC, UAE, a wholly-owned subsidiary of Shilpa Medicare and Pharma Pharmaceutical Industries & Biological Products (PPI), a prominent Saudi enterprise, have announced a definitive agreement to form a new joint venture company based in the Kingdom of Saudi Arabia.

Leveraging their respective strengths, PPI will contribute its local market expertise, while the Shilpa Group will provide global R&D, manufacturing, and regulatory capabilities.

The new limited liability company will be majority owned by PPI (70%), with Koanna holding a 30% stake.

The partnership will be executed in two key phases to ensure a swift market entry and a long-term manufacturing strategy:

 Phase One: Shilpa Group will supply finished products in bulk for repackaging at the new JV company's state-of-the-art facility. This ensures a rapid market entry for key products. Concurrently, PPI will be responsible for establishing this fully-equipped manufacturing facility with technical input from Shilpa Group.

 Phase Two: Shilpa Group will execute a full technology transfer of its manufacturing processes to the JV. This will empower the JV to commence local production of finished products. As part of the agreement, Shilpa Group will provide technical support for the transfer of the project site to the JV Company. PPI will be responsible for equipping the facility with all necessary infrastructure and packaging equipment to meet international standards. Shilpa Group will be responsible for preparing the complete regulatory registration dossier in compliance with the Saudi Food and Drug Authority (SFDA) and will lead the process of obtaining the necessary Market Authorization.

Wael B Aldahhasi, Chairman, PPI said, “Partnering with Shilpa Group allows us to bring world-class manufacturing technology and expertise to the Kingdom. This initiative will accelerate our ability to meet the growing healthcare needs of Saudi Arabia with locally manufactured, high-quality medicines”.

Vishnukant Bhutada, MD of Shilpa Medicare Ltd said, “We are excited to partner with PPI, this JV combines PPI's unmatched local strength with Shilpa’s innovative technology to improve healthcare in the Kingdom. PPI is the ideal partner to make our products more accessible. This JV underscores our commitment to Saudi Arabia and will consolidate our presence across the MENA region.”

Pharma Pharmaceutical Industries & Biological ProductsKoanna Internationalshilpa medicare

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751